Quarterly report pursuant to Section 13 or 15(d)

Stock-Based Compensation - Liberty - Outstanding Awards (Details)

v3.20.2
Stock-Based Compensation - Liberty - Outstanding Awards (Details)
$ / shares in Units, $ in Millions
 6 Months Ended
Jun. 30, 2020
USD ($)
$ / shares
shares
Additional disclosures  
Total unrecognized compensation cost related to unvested equity awards | $ $ 35
Weighted average period of recognition related to unvested equity awards (in years) 2 years 1 month 6 days
Liberty SiriusXM Group  
Additional disclosures  
Common stock reserved for issuance 10,100,000
Liberty SiriusXM Group | Common Class A  
Number of options  
Outstanding at beginning of period 22,000
Granted 0
Exercised (17,000)
Outstanding at end of period 5,000
Exercisable at end of period 5,000
WAEP  
Outstanding at beginning of period | $ / shares $ 22.62
Exercised | $ / shares 19.94
Outstanding at end of period | $ / shares 31.00
Exercisable at end of period | $ / shares $ 31.00
Additional disclosures  
Weighted average remaining life, outstanding 4 months 24 days
Weighted average remaining life, exercisable 4 months 24 days
Liberty SiriusXM Group | Common Class B  
Number of options  
Granted 0
Liberty SiriusXM Group | Common Class C  
Number of options  
Outstanding at beginning of period 9,817,000
Granted 401,000
Exercised (119,000)
Outstanding at end of period 10,099,000
Exercisable at end of period 7,975,000
WAEP  
Outstanding at beginning of period | $ / shares $ 33.90
Granted | $ / shares 39.61
Exercised | $ / shares 28.47
Outstanding at end of period | $ / shares 34.19
Exercisable at end of period | $ / shares $ 32.24
Additional disclosures  
Weighted average remaining life, outstanding 3 years 3 months 18 days
Weighted average remaining life, exercisable 2 years 8 months 12 days
Aggregate intrinsic value, outstanding | $ $ 31
Aggregate intrinsic value, exercisable | $ $ 29
Formula One Group  
Additional disclosures  
Common stock reserved for issuance 10,000,000.0
Formula One Group | Common Class A  
Number of options  
Outstanding at beginning of period 1,000
Granted 0
Outstanding at end of period 1,000
Exercisable at end of period 1,000
WAEP  
Outstanding at beginning of period | $ / shares $ 12.63
Outstanding at end of period | $ / shares 12.63
Exercisable at end of period | $ / shares $ 12.63
Additional disclosures  
Weighted average remaining life, outstanding 2 years 6 months
Weighted average remaining life, exercisable 2 years 6 months
Formula One Group | Common Class B  
Number of options  
Granted 0
Formula One Group | Common Class C  
Number of options  
Outstanding at beginning of period 8,284,000
Granted 1,694,000
Exercised (21,000)
Outstanding at end of period 9,957,000
Exercisable at end of period 7,339,000
WAEP  
Outstanding at beginning of period | $ / shares $ 31.16
Granted | $ / shares 28.64
Exercised | $ / shares 17.79
Outstanding at end of period | $ / shares 30.76
Exercisable at end of period | $ / shares $ 30.01
Additional disclosures  
Weighted average remaining life, outstanding 4 years 9 months 18 days
Weighted average remaining life, exercisable 4 years 2 months 12 days
Aggregate intrinsic value, outstanding | $ $ 28
Aggregate intrinsic value, exercisable | $ $ 21
Braves Group  
Additional disclosures  
Common stock reserved for issuance 1,400,000
Braves Group | Common Class A  
Number of options  
Outstanding at beginning of period 2,000
Granted 0
Outstanding at end of period 2,000
Exercisable at end of period 2,000
WAEP  
Outstanding at beginning of period | $ / shares $ 11.89
Outstanding at end of period | $ / shares 11.89
Exercisable at end of period | $ / shares $ 11.89
Additional disclosures  
Weighted average remaining life, outstanding 2 years
Weighted average remaining life, exercisable 2 years
Braves Group | Common Class B  
Number of options  
Granted 0
Braves Group | Common Class C  
Number of options  
Outstanding at beginning of period 1,267,000
Granted 143,000
Exercised (11,000)
Outstanding at end of period 1,399,000
Exercisable at end of period 815,000
WAEP  
Outstanding at beginning of period | $ / shares $ 21.82
Granted | $ / shares 20.12
Exercised | $ / shares 16.24
Outstanding at end of period | $ / shares 21.69
Exercisable at end of period | $ / shares $ 18.84
Additional disclosures  
Weighted average remaining life, outstanding 4 years 1 month 6 days
Weighted average remaining life, exercisable 2 years 7 months 6 days
Aggregate intrinsic value, outstanding | $ $ 2
Aggregate intrinsic value, exercisable | $ $ 2